Dechra Pharmaceuticals PLC Director Declaration (8392K)
18 December 2018 - 10:07PM
UK Regulatory
TIDMDPH TIDMULE
RNS Number : 8392K
Dechra Pharmaceuticals PLC
18 December 2018
18 December 2018
Dechra(R) Pharmaceuticals PLC
("Dechra" or "the Company")
Director's Declaration
In accordance with Listing Rule 9.6.14(2) Dechra announces that
Tony Rice, Non-Executive Chairman of Dechra, is to be appointed as
a Non-Executive Director of Ultra Electronics Holdings plc with
effect from 18 December 2018 and its Chair from 28 January
2019.
For further information:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Its expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNBBBDDUGBBGII
(END) Dow Jones Newswires
December 18, 2018 06:07 ET (11:07 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024